Litigation Details for Kowa Company, Ltd. v. Aurobindo Pharma Limited (S.D.N.Y. 2014)
✉ Email this page to a colleague
Kowa Company, Ltd. v. Aurobindo Pharma Limited (S.D.N.Y. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-09 |
| Court | District Court, S.D. New York | Date Terminated | 2015-12-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Paul Austin Crotty |
| Jury Demand | Defendant | Referred To | |
| Parties | NISSAN CHEMICAL INDUSTRIES, LTD. | ||
| Patents | 6,465,477; 8,557,993 | ||
| Attorneys | David Cotta | ||
| Firms | Locke Lord LLP (NYC) | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Kowa Company, Ltd. v. Aurobindo Pharma Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Kowa Company, Ltd. v. Aurobindo Pharma Limited (S.D.N.Y. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-04-09 | 2 | United States Patent No. 8,557,993 ("Ihe'993 patent"), entitled "Crystalline … of 50 U.S. Patent oct.ts,2ot3 sheer3 of 9 us 8,557,993 B2 … 50 U.S. Patent ocr. 15, 2ot3 sheer 5 of 9 us 8,557,993 B2 …50 U.S. Patent ocr. 15, 2013 Sheer 6 of 9 us 8,557,993 B2 … of 50 U.S. Patent ocr. 15,2013 sheer 7 of 9 us 8,557,993 B2 | External link to document | |
| 2015-11-03 | 93 | infringing U.S. Patent Nos. 5,856,336 (“the ‘336 Patent”); 6,465,477 (“the ‘477 Patent”); and 8,557,993…the ‘993 Patent”). Defendants seek claim construction of the ‘336 Patent and the ‘477 Patent; Plaintiffs…Apotex”). 2 The ‘336 Patent is not at issue in the Apotex case. The ‘477 Patent is not at issue in the…Fed. Cir. 2008). II. The ‘336 Patent The ‘336 Patent consists of two claims. Claim 1 describes…construction is unnecessary. III. The ‘477 Patent The ‘477 Patent states that pitavastatin calcium (also | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
